Previous studies have suggested that HLA–DRB1 alleles may have disease‐modifying effects in IBM, with the HLA–DRB1*03/*01 genotype conferring an earlier age at onset and more severe muscle weakness 5, 28. This evidence concerns the gene HLA-DRB1 and inclusion body myositis.